Francisco J. Feo-Brito

Prof. Dr. Francisco J. Feo-Brito

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Plant Physiology and Biochemistry
Verified
Journal Article
Closed access
JLJose Antonio Lucas
Jose Antonio Lucas
EAEnrique Gutiérrez Albanchez
Enrique Gutiérrez Albanchez
TATeresa Alfaya
Teresa Alfaya
FFFrancisco J. Feo-Brito
Francisco J. Feo-Brito
FGF. Javier Gutierrez-Manero
F. Javier Gutierrez-Manero

1 January 2012
Verified
Journal Article
Closed access
FFFrancisco J. Feo-Brito
Francisco J. Feo-Brito
AAA M Alonso
A M Alonso
Jeronimo CarnesJeronimo Carnes
Jeronimo Carnes
Raúl Martín-MartínRaúl Martín-Martín
Raúl Martín-Martín
EFE Fernández-Caldas
E Fernández-Caldas
Mariano Amo-SalasMariano Amo-Salas
Mariano Amo-Salas

27 August 2013 in Allergy, Asthma & Clinical Immunology
Verified
Journal Article
Open access
PDF file
POPedro Ojeda
Pedro Ojeda
NPnuria pique
nuria pique
AAAlicia Alonso
Alicia Alonso
JDJulio Delgado
Julio Delgado
FFFrancisco J. Feo-Brito
Francisco J. Feo-Brito
MAMorgan Andersson
Morgan Andersson
Since barrier protection measures to avoid contact with allergens are being increasingly developed, we assessed the clinical efficacy and tolerability of a topical nasal microemulsion made of glycerol esters in patients with allergic rhinitis.

6 November 2021 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
FFFrancisco Feo‐Brito
Francisco Feo‐Brito
TATeresa Alfaya
Teresa Alfaya
Mariano Amo-SalasMariano Amo-Salas
Mariano Amo-Salas
MÁMaría Luisa Somoza Álvarez
María Luisa Somoza Álvarez
EDElisa Haroun Díaz
Elisa Haroun Díaz
JUJose M URRA
Jose M URRA

24 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MIMARIA ARANZAZU MARTIN IGLESIAS
MARIA ARANZAZU MARTIN IGLESIAS
RRRosa Garcia Rodriguez
Rosa Garcia Rodriguez
ACAlberto Palacios Cañas
Alberto Palacios Cañas
JSJaime Vinicio Meneses Sotomayor
Jaime Vinicio Meneses Sotomayor
MCMiriam Clar Castello
Miriam Clar Castello
FFFrancisco J. Feo-Brito
Francisco J. Feo-Brito
Introduction: SLIT for the treatment of plant food allergies has been demonstrated to be safe but less effective than OIT, but the latter is associated with more adverse reactions. The aim of the study was to evaluate the efficacy and safety of a new protocol starting with SLIT-peach followed by OIT with commercial peach juice in patients with LTP syndrome. Methods: This was a prospective, noncontrolled, open study on patients with LTP syndrome who are not sensitized to storage proteins. SLIT peach ALK was followed by OIT with Granini® peach juice after 40 days of the SLIT maintenance phase. At home, the Granini® juice dose was progressively increased during the 42 days until reaching 200 ml. After achieving the maximum dose, an open oral food challenge was carried out with the food that had caused the most severe reaction. If negative, the patient was instructed to progressively introduce the foods that were avoided before starting immunotherapy at home. Patients were reviewed 1 month later. The quality-of-life questionnaire FAQLQ-AF was completed at the beginning of the study and one month after the final challenge. Results: Forty-five patients were included, most of them with LTP anaphylaxis. Peach SLIT was well tolerated in 80.5%, and OIT with Granini® was well tolerated in 85%, with no severe adverse reactions. The final provocation was successful in 39/45 (86.6%). One month after the final provocation, 42/45 (93.3%) patients had no dietary restrictions. FAQLA-AF was significantly reduced. Conclusions: This combination of peach SLIT and OIT with commercial peach juice provides a new, fast, effective, and safe immunotherapy option for selected patients with LTP syndrome who are not allergic to storage proteins, improving their quality of life. This study suggests that cross-desensitization relative to the nsLTPs of several plant foods can be achieved by using Prup3.

6 November 2020 in Plants
Verified
Journal Article
Open access
PDF file
JLJose Antonio Lucas
Jose Antonio Lucas
EAEnrique Gutiérrez Albanchez
Enrique Gutiérrez Albanchez
TATeresa Alfaya
Teresa Alfaya
FFFrancisco J. Feo-Brito
Francisco J. Feo-Brito
FGF. Javier Gutierrez-Manero
F. Javier Gutierrez-Manero
The relationship between air pollution and the allergenic capacity of pollen is widely accepted, with allergenicity being directly related to air pollution. To our knowledge, this is the first study comparing the differential expression of Lolium perenne pollen genes by RNAseq, in two wild populations with different levels of air pollution. The objective is to search for proteins that are expressed differentially in both situations and to establish a relationship with increased allergenic capacity. Two populations of L. perenne (Madrid and Ciudad Real) have been studied in two consecutive years, under the rationale that overexpressed genes in Madrid, with higher levels of NO2 and SO2, could be a cause for their greater allergenic capacity. Heat shock proteins (HSP), glycoside hydrolases, proteins with leucin-rich repeat motifs, and proteins with EF-HAND motifs were consistently overexpressed in Madrid pollen in the two years studied. Interestingly, some genes were overexpressed only in one of the years studied, such as pectinesterases in the first year, and lipid transfer proteins (LTPs) and thaumatin in the second. Despite the fact that the potential of all these proteins in relation to possible allergies has been reported, this is the first time they are cited as possible allergens of L. perenne. The results found can contribute decisively to the knowledge of the allergens of L. perenne and their relationship with atmospheric pollution, and to the development of much more effective vaccines.